21025 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Transferases (2)
Compositions for treating heart disease by inhibiting the action of mAKAP-β
#302METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS
#303MYC, CYCLIN T1 AND/OR CDK9 FOR USE IN THE TREATMENT OF DEGENERATIVE HEART AND CNS DISORDERS
#304Peptides for treatment and prevention of diabetes and associated disorders
#305DESIGN AND OPTIMIZATION OF TYPE IV BRAF INHIBITORS FOR THE TREATMENT OF MELANOMA
#306METHOD FOR TREATING AND/OR PREVENTING REGNASE-1-RELATED DISEASE
#307METHOD FOR TREATING COLORECTAL CANCER
#308ALK7:ActRIIB heteromultimers and uses thereof
#309COMPOSITION AND METHODS FOR MODULATION OF ELOVL2
#310COMPOSITIONS AND METHODS FOR INHIBITING YEAST INFECTIONS
#311IMMUNOMODULATORY COMPOSITIONS AND METHODS
#312PEPTIDES WITH ANTI-TUMOR ACTIVITY
#313TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#314Compositions and Methods for the Treatment of Genetic Diseases
#315NME INHIBITORS AND METHODS OF USING NME INHIBITORS
#316Methods and compositions for delivery of agents across the blood-brain barrier
#317MULTIMERIC CODING NUCLEIC ACID AND USES THEREOF
#318Composition and methods for treatment of ornithine transcarbamylase deficiency
#319ASH1L degraders and methods of treatment therewith
#320BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP
#321PEG lipidoid compounds
#322ENHANCING EPITHELIAL OR ENDOTHELIAL BARRIER FUNCTION
#323METHODS OF TREATING CANCER
#324MOLECULAR SIGNATURE OF CANCER
#325mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
#326Choline acetyltransferase as a therapy for hypertension
#327Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
#328Methods of administering 3,4-diaminopyridine
#329Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
#330Methods of administering 3,4-diaminopyridine
#331Methods of administering 3,4-diaminopyridine
#332Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
#333ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCELOSIDE HYDROLASE PRODRUG
#334Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#335Methods of treating or preventing cancer with an agent that depletes tregs and a checkpoint inhibitor
#336FUSOSOME COMPOSITIONS FOR CNS DELIVERY
#337Thioester cationic lipids
#338TRINUCLEOTIDE CAP ANALOGS, PREPARATION AND USES THEREOF
#339Compositions and methods comprising the use of a inulosucrase (INUO)
#340Combination Therapy Method of Treating Myeloproliferative Neoplasms with a Diphtheria Toxin-Human Interleukin-3 Conjugate in Combination with Other Agents
#341Anti-inflammatory peptides and composition comprising the same
#342SPHINGOSINE KINASE 1 AND FUSION PROTEIN COMPRISING THE SAME AND USE THEREOF
#343Dry Powder Formulations for Messenger RNA
#344METHODS OF INHIBITING PROLIFERATIVE CELLS
#345HEALTH MANAGEMENT COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#346Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#347ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#348Synthetic lipid-like materials for brain delivery
#349METHODS AND SYSTEMS FOR MODIFYING DNA
#350Compositions for use to treat advanced glycation end products-dependent ocular diseases
#351COMPOSITIONS AND METHOD FOR MANIPULATING PIM-1 ACTIVITY IN CIRCULATORY SYSTEM CELLS
#352DELIVERY OF NEGATIVELY CHARGED PROTEINS USING CATIONIC LIPIDS
#353TREATMENT OF FLAVIVIRUS INFECTIONS IN HUMANS USING MUS MUSCULUS RESISTANT 2'-5' OLIGOADENYLATE SYNTHETASE 1B
#354COMPOSITIONS OF STING VARIANTS, COMBINATIONS THEREOF, AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE AGAINST INFECTIONS, DISEASES, AND DISORDERS
#355METHODS, COMPOSITIONS, AND KITS FOR IMPROVING PANCREATIC BETA CELL VIABILITY AND TREATING DISEASES OR CONDITIONS RELATED TO BETA CELL DESTRUCTION
#356Therapy for mitochondrial fatty acid beta-oxidation and transport disorders
#357MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#358Gene therapy for NMNAT1-associated retinal degeneration
#359USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION
#360Compositions and methods for treating pulmonary hypertension
#361Compositions and methods for treating pulmonary hypertension
#362Platelet lysate compositions and uses thereof
#363Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
#364METHODS AND COMPOSITIONS FOR DELIVERY OF AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#365Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof
#366INACTIVATION OF DNA REPAIR AS AN ANTICANCER THERAPY
#367TATk-CDKL5 Fusion Proteins, Compositions, Formulations, and Use Thereof
#368Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#369TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#370COMPOSITIONS AND METHODS OF FAS INHIBITION
#371Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#372COMPOSITIONS AND METHODS FOR IN VIVO POST TRANSLATIONAL MODIFICATION
#373VECTOR PRODUCTION IN SERUM FREE MEDIA
#374Inhibition of diacylglycerol kinase to augment adoptive T cell transfer
#375Anti-inflammatory peptides and composition comprising the same
#376Methods and materials for GALGT2 gene therapy
#377Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#378Pharmaceutical compositions for the treatment of cancer
#379Cationic lipids comprising a steroidal moiety
#380METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS
#381Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency
#382CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO
#383Recombinant replication competent viruses comprising a coding region for glycogen synthase kinase-3 (GSK3) and methods of killing aberrant cells
#384CYTOBIOLOGICS AND THERAPEUTIC USES THEREOF
#385Methods of treating cancers
#386STRUCTURE, MANUFACTURING AND USES OF HUMAN-DERIVED CELL-PERMEABLE PEPTIDES CONJUGATED WITH SPECIFIC BIOLOGICALLY ACTIVE CARGO PEPTIDES
#387Larval preparation of Heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof
#388TREATMENT OF A SUBTYPE OF ASD
#389CELLULAR COMPOSITIONS AND METHODS OF TREATMENT I
#390NUCLEIC ACID MODIFICATION WITH TOOLS FROM OXYTRICHA
#391Methods for treating or alleviating a bone-loss related disease or condition by administering a nucleic acid encoding a discoidin domain receptor 1 (DDR1) protein
#392Therapeutic constructs for treating cancer
#393Compositions and methods for detoxifying bacterial endotoxins
#394COMPOUNDS AND METHODS FOR THE IMMOBILIZATION OF MYOSTATIN-INHIBITORS ON THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE
#395COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY
#396Methods for treating cardiac conditions
#397Azaindolylpyridone and diazaindolylpyridone compounds
#398Functionalized DNA Dendrimers For Gene Delivery To Cells
#399COMPOSITIONS AND METHODS FOR THE TREATMENT OF ISCHEMIA AND CARDIOMYOPATHY
#400COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION
#401Cationic polymers
#402GENE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
#403GNE as a therapeutic agent
#404Enzyme-mediated depletion of adenosine and/or methylthioadenosine
#405Cancer stem cell targeted cancer vaccines
#406TRANSDUCTION BUFFER
#407Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis
#408Anti-inflammatory peptides and composition comprising the same
#409SUPERACTIVE MUTANT THYMIDINE KINASE FOR USE IN CANCER THERAPY
#410COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#411IN VIVO PRODUCTION OF PROTEINS
#412Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same
#413VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME
#414Use of pertussis toxin as a therapeutic agent
#415Target for diabetes treatment and prevention
#416INTRACELLULAR DELIVERY OF TARGET-SILENCING PROTEIN
#417METHODS OF IMMUNOSTIMULATION WITH COMPLEXES OF RNA AND CATIONIC CARRIERS
#418ENZYME-MEDIATED DEPLETION OF ADENOSINE AND/OR METHYLTHIOADENOSINE
#419Compositions and methods for facilitating delivery of synthetic nucleic acids to cells
#420METHODS FOR TREATING FLAVIVIRUSES AND ZIKA INFECTIONS
#421ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES
#422CELLS GENETICALLY MODIFIED TO COMPRISE PANCREATIC ISLET GLUCOKINASE AND USES THEREOF
#423Compositions for use to treat cataract
#424Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification
#425USE OF AXL, CCL19 AND/OR BMP-6 FOR PROMOTING WOUND HEALING
#426Compositions and methods for treating pulmonary hypertension
#427PEPTIDES FOR TREATMENT OF DIABETES
#428Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor
#429Methods of treating the deleterious effects of excessive use of drugs and alcohol
#430Methods of Administering 3,4-Diaminopyridine
#431Methods of Administering 3,4-Diaminopyridine
#432Methods of Administering 3,4-Diaminopyridine
#433Methods of administering 3,4-diaminopyridine
#434COMPOSITIONS OF PARP14 MODULATORS AND/OR MUTANTS AND THERAPEUTIC USE THEREOF
#435ALK polypeptides and methods of use thereof
#436Compositions and methods for treating pulmonary hypertension
#437Targeting NAD+ to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity
#438Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)
#439Compositions and methods for treating pulmonary hypertension
#440Compositions and methods for treating pulmonary hypertension
#441Active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof
#442PROLIFERATION OF MUC1 EXPRESSING CELLS
#443Compositions and methods for treating pulmonary hypertension
#444PHARMACEUTICAL COMPOSITION, USE AND METHOD FOR FISTULA TREATMENT IN CHILDREN
#445CELL PROLIFERATION INHIBITOR AND CANCER TREATMENT OR PREVENTION PHARMACEUTICAL COMPOSITION INCLUDING CELL PROLIFERATION INHIBITOR
#446Peptides and other agents for treating pain and increasing pain sensitivity
#447SYSTEM AND METHODS TO PROMOTE CELLULAR REGENERATION FOLLOWING ISCHEMIA
#448Vault complexes for cytokine delivery
#449Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
#450Using nucleic acids encoding NAP-2 polypeptides to improve cardiac function
#451TETRAHYDROCANNABINOL MODULATORS
#452CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALLING SYSTEM
#453SYSTEMS, METHODS, AND COMPOSITIONS TO IDENTIFY NEW PROTEIN TARGETS OF A CHEMICAL COMPOUND OR ITS DERIVATIVES
#454DELIVERY SYSTEM FOR FUNCTIONAL NUCLEASES
#455Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#456FUSION PROTEINS
#457Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#458Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#459Compositions for treating heart disease by inhibiting the action of mAKAPβ
#460METHODS OF TREATING METASTATIC CANCERS USING AXL DECOY RECEPTORS
#461ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#462Compounds, compositions, methods, and kits relating to telomere extension
#463Treatments of oxidative stress conditions
#464Compositions and methods for the treatment of cancer
#465Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
#466COMPOSITIONS AND METHODS FOR SUPPRESSION OF INHIBITOR FORMATION AGAINST COAGULATION FACTORS IN HEMOPHILIA PATIENTS
#467METHODS OF TREATING AND PROTECTING AGAINST CARDIAC DISEASE, CARDIOVASCULAR DISEASE AND RELATED CONDITIONS AND SYMPTOMS
#468Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells
#469Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#470ASH1L inhibitors and methods of treatment therewith
#471TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#472AN ANTI-APOPTOTIC FUNCTION OF PKM2 AND INTRACELLULARLY EXPRESSED SCFV ANTIBODIES
#473Cleavable lipids
#474Recombinant AAV vectors expressing osteoprotective genes, including HAS2 and lubricin, useful in the treatment of osteoarthritis and related joint conditions in mammals
#475ACTIVATING MITOTIC CHECKPOINT CONTROL MECHANISMS
#476LUNG CELL TREATMENTS TO PREVENT OR TREAT DISEASE
#477ITDC COMPOSITIONS AND METHODS FOR USE IN THERAPEUTIC METHODS
#478Compounds, compositions, methods, and kits relating to telomere extension
#479Compounds, compositions, methods, and kits relating to telomere extension
#480Anti-inflammatory peptides and composition comprising same
#481NEUKINASE, A DOWNSTREAM PROTEIN OF NEUREGULIN
#482Single-vector gene construct comprising insulin and glucokinase genes
#483Therapeutic agent for diseases associated with abnormalities in dystroglycan sugar chain modification and method for assaying associated enzyme
#484Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof
#485Multimeric coding nucleic acid and uses thereof
#486SELECTIVE DESTRUCTION OF CELLS
#487Methods for inducing cell division of postmitotic cells
#488Ligand binding molecules and uses thereof
#489Inhibiting FAK-AKT interaction to inhibit metastasis
#490Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#491Use of pertussis toxin as a therapeutic agent
#492Therapeutic compositions and methods of use for treating cancer
#493Methods and compositions of use of CD8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof
#494Regulation of RAN translation by PKR and eIF2A-P pathways
#495ANTI-INFLAMMATORY PEPTIDES AND COMPOSITION COMPRISING THE SAME
#496m6A mRNA MODIFICATION IN CANCER TREATMENT
#497Method for treating damage induced by sleep deprivation
#498HLA-A2 subtype-specific PLK1-derived epitope inducing antigen-specific t cell immune response to PLK1 protein
#499METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
#500Protein Kinase C-delta targeted therapy for treating radiation injury
#501Human microbiota derived N-acyl amides for the treatment of human disease
#502Methods and compositions for treating ulcers
#503Transgene-Cytotoxic Combination Therapy
#504Peptides for treatment of diabetes
#505Mutant huntingtin-mediated protein dysfunction
#506POLYNUCLEOTIDES ENCODING PORPHOBILINOGEN DEAMINASE FOR THE TREATMENT OF ACUTE INTERMITTENT PORPHYRIA
#507Peptides and compositions for treatment of joint damage
#508METHOD
#509Viral vectors for treating neurogenic detrusor overactivity
#510Compositions for facilitating membrane fusion and uses thereof
#511Methods and products for nucleic acid production and delivery
#512METHOD FOR DETERMINING, PREDICTING AND TREATING CANCER
#513Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases
#514Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#515METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
#516Homogenous antibody drug conjugates via enzymatic methods
#517REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#518Compositions and methods for oral delivery of therapeutic cargo
#519USE OF PHOSPHORYLATED TAU AND P38GAMMA TO TREAT A NEUROLOGICAL CONDITION
#520Nanocomplexes of polyanion-modified proteins
#521ALK7:actriib heteromultimers and uses thereof
#522TREATMENT OF HYPERBILIRUBINEMIA
#523ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS
#524MODULATION OF ISCHEMIC CELL BIOENERGETICS
#525Methods for predicting responsiveness of a cancer to an immunotherapeutic agent and methods of treating cancer
#526Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
#527Inhibiting the onset of gout
#528PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RETINAL DEGENERATIVE DISEASES
#529Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
#530In vivo production of proteins
#531Gene therapy
#532Application of PI4KIIIA protein and related membrane protein complex in treating alzheimer's disease
#533Cleavable lipids
#534SINGLE-DOSE ADMINISTRATION OF FACTOR VIIa
#535MODIFIED mRNA ENCODING A URIDINE DIPHOPSPHATE GLUCURONOSYL TRANSFERASE AND USES THEREOF
#536Compositions targeting the interaction domain between p27Kip1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#537Methods and compositions for in vivo induction of pancreatic beta cell formation
#538Subcutaneous delivery of messenger RNA
#539Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#540COMPOSITIONS AND USES THEREOF
#541Therapy for mitochondrial fatty acid beta-oxidation and transport disorders
#542Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization
#543Compositions comprising a lecithin cholesterol acyltransferase variant and uses thereof
#544CBL-FAMILY INHIBITOR COMPRISING A CBL-FAMILY TKB DOMAIN BINDING PEPTIDE FOR THE PREVENTION OR TREATMENT OF DISEASES
#545Multimeric coding nucleic acid and uses thereof
#546COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#547MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
#548Recombinant Dgkk gene for fragile X syndrome gene therapy
#549TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof
#550METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#551COMPOSITIONS AND METHODS OF FAS INHIBITION
#552Methods of treating hypertension
#553Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients
#554Composition and methods for treatment of ornithine transcarbamylase deficiency
#555Anti-inflammatory peptides and compositions comprising the same
#556Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
#557METHODS OF TREATING A SUBJECT HAVING GLYCOGEN STORAGE DISEASE WITH mRNA ENCODING GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT (G6PC)
#558METHODS OF TREATING A SUBJECT HAVING PROPIONIC ACIDEMIA WITH mRNA ENCODING PROPIONYL-COA CARBOXYLASE, SUBUNIT ALPHA AND/OR BETA (PCCA AND/OR PCCB)
#559METHODS OF TREATING A SUBJECT HAVING CITRULLINEMIA WITH mRNA ENCODING ARGININOSUCCINATE SYNTHASE (ASS)
#560METHODS OF TREATING A SUBJECT HAVING FRIEDREICH'S ATAXIA WITH mRNA ENCODING FRATAXIN
#561METHODS OF TREATING A SUBJECT HAVING GLYCOGEN STORAGE DISEASE II WITH mRNA ENCODING ACID GLUCOSIDASE ALPHA (GAA)
#562METHODS OF TREATING A SUBJECT WITH mRNA ENCODING COAGULATION FACTOR VIII (F8)
#563METHODS OF TREATING PHENYLKETONURIA WITH MRNA ENCODING PHENYLALANINE HYDROXYLASE (PAH)
#564Therapeutic combinations to treat red blood cell disorders
#565Peptides and compositions for treatment of joint damage
#566Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#567Aldehyde tags, uses thereof in site-specific protein modification
#568ASH1L inhibitors and methods of treatment therewith
#569ASH1L degraders and methods of treatment therewith
#570Challenge test for diagnosing subtypes of ASD
#571Method of identifying ASD phenotype 1 patients
#572Method of Restoring the Incretin Effect
#573Methods and compositions for treating metabolic imbalance
#574COMPOSITIONS AND METHODS FOR OLIGODENDROCYTE DEVELOPMENT
#575Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#576Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#577Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#578Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#579ANIMAL MODEL FOR STUDYING ZCCHC6 IN BONE DISEASE AND DEVELOPMENT
#580Single dose administration of factor VIIa
#581METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM
#582Compositions and methods for treating or preventing oxalate-related disease
#583Antiviral proteins and their uses in therapeutic methods
#584Antibacterial composition containing ADK protein as active ingredient, or composition for preventing or treating sepsis
#585Compositions for preventing or treating sepsis or septic shock compromising ADK protein as active ingredient
#586COMPOSITIONS AND METHOD FOR MANIPULATING PIM-1 ACTIVITY IN CIRCULATORY SYSTEM CELLS
#587Drug delivery means
#588Permanent epigenetic gene silencing
#589Anti-inflammatory peptides and composition comprising the same
#590CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME
#591Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#592Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction
#593Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer
#594SINGLE-DOSE ADMINISTRATION OF FACTOR VIIa
#595Placental tissue composition for for treating cardiac tissue damage
#596MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES
#597ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCLEOSIDE HYDROLASE PRODRUG
#598TELOMERE EXTENSION AND ANTI-INFLAMMATORY AGENTS FOR CELL REGENERATION
#599Oncological and Neurological Therapy based on ATM, CHK2 and p53 proteins for DNA correction of transcription errors
#600Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies